Previous close | 21.62 |
Open | 21.44 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 21.30 - 21.52 |
52-week range | 11.61 - 22.87 |
Volume | |
Avg. volume | 1,791,825 |
Market cap | 19.667B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 0.06 |
EPS (TTM) | 3.49 |
Earnings date | 28 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the Asia Pacific (APAC) findings of its Future Health Index (FHI) 2024 report: Better care for more people. The ninth edition of the report, which surveyed nearly 3,000 healthcare leaders in 14 countries, including Australia, Indonesia, and Singapore, shows that healthcare leaders are focusing on improving operational efficiencies through workflow prioritization, data integration, and AI-enabled innovation
Philips Azurion Carilion Cardiovascular Institute Philips Azurion EP August 20, 2024 Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE: PHG, AE
CAMBRIDGE, Mass. & ROANOKE, Va., August 20, 2024--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a not-for-profit health care organization serving more than one million people in Virginia and West Virginia, today announced Carilion will adopt the Philips cardiovascular care ecosystem of solutions at the future home of its Cardiovascular Institute at Crystal Spring Tower. Carilion will have 11 specialized Philips interventional suites, allowing ph